4.7 Article

Gaps in Referral to Cardiac Rehabilitation of Patients Undergoing Percutaneous Coronary Intervention in the United States

Journal

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
Volume 65, Issue 19, Pages 2079-2088

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.jacc.2015.02.063

Keywords

cardiac rehabilitation; percutaneous coronary intervention; quality of care; secondary prevention

Funding

  1. Amarin
  2. AstraZeneca
  3. Bristol-Myers Squibb
  4. Eisai
  5. Ethicon
  6. Medtronic
  7. Sanofi
  8. Medicines Company
  9. Eli Lilly
  10. Revalesio
  11. American College of Cardiology
  12. American Heart Association
  13. Familial Hyperlipidemia Foundation
  14. National Institutes of Health
  15. Agency for Health Care Research and Quality

Ask authors/readers for more resources

BACKGROUND Rates of referral to cardiac rehabilitation after percutaneous coronary intervention (PCI) have been historically low despite the evidence that rehabilitation is associated with lower mortality in PCI patients. OBJECTIVES This study sought to determine the prevalence of and factors associated with referral to cardiac rehabilitation in a national PCI cohort, and to assess the association between insurance status and referral patterns. METHODS Consecutive patients who underwent PCI and survived to hospital discharge in the National Cardiovascular Data Registry between July 1, 2009 and March 31, 2012 were analyzed. Cardiac rehabilitation referral rates, and patient and institutional factors associated with referral were evaluated for the total study population and for a subset of Medicare patients presenting with acute myocardial infarction. RESULTS Patients who underwent PCI (n = 1,432,399) at 1,310 participating hospitals were assessed. Cardiac rehabilitation referral rates were 59.2% and 66.0% for the overall population and the AMI/Medicare subgroup, respectively. In multivariable analyses, presentation with ST-segment elevation myocardial infarction (odds ratio 2.99; 95% confidence interval: 2.92 to 3.06) and non-ST-segment elevation myocardial infarction (odds ratio: 1.99; 95% confidence interval: 1.94 to 2.03) were associated with increased odds of referral to cardiac rehabilitation. Models adjusted for insurance status showed significant site-specific variability in referral rates, with more than one-quarter of all hospitals referring <20% of patients. CONCLUSIONS Approximately 60% of patients undergoing PCI in the United States are referred for cardiac rehabilitation. Site-specific variation in referral rates is significant and is unexplained by insurance coverage. These findings highlight the potential need for hospital-level interventions to improve cardiac rehabilitation referral rates after PCI. (C) 2015 by the American College of Cardiology Foundation.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available